Alcoholic pump foam

Information

  • Patent Grant
  • 8124115
  • Patent Number
    8,124,115
  • Date Filed
    Monday, November 23, 2009
    15 years ago
  • Date Issued
    Tuesday, February 28, 2012
    12 years ago
Abstract
An alcoholic foam composition, which can be dispensed as a foam via a pump-foam system contains a) at least 52 to ≦99 wt % of an alcohol or mixture of alcohols, b) a surfactant or a surfactant mixture, c) at least one polyalkylene glycol, d) optionally, at least one foam stabilizer, e) optionally, at least one member selected from the group consisting of cosmetic auxiliaries, adjuvants, active ingredients, and mixtures thereof, and f) optionally water. The surface tension of component b) lies in the range of ±15 dyn/cm of the surface tension of component a) or corresponds to the surface tension of component a), and the sum of components a) to f) is 100 wt % relative to the total quantity of the foam composition.
Description
BACKGROUND OF THE INVENTION

1. Field of the Invention


The present invention relates to alcoholic foam compositions.


2. Discussion of the Background


Disinfectants are used to combat pathogenic microorganisms such as bacteria, viruses, spores, fungi, etc. The use of disinfectants is unavoidable in many regions or the use is expressly required by the legislators in many countries.


Disinfectants are usually classified according to their area of application and, depending on intended use, a distinction is made between antiseptics for wound, skin, stools and sputum disinfection as well as instruments disinfection, laundry and surface disinfectants, and especially also skin and hand disinfectants.


The area of application of the aforesaid disinfectants is medically indicated and they are used for prevention of infections in hospitals, doctors' and dentists' offices, in public areas such as schools, kindergartens, nursing institutions, retirement homes, sanatoriums, etc., and also in sports facilities and other places in which infections can be transmitted. Besides the use of disinfectants in the food industry and pharmaceutical industry, they are in general use not only at the workplace or in the home, but also in service industries such as laundries and kitchens, where the products are delivered directly to patients or consumers.


Demonstration of the effectiveness of such disinfecting agents for one or more of the aforesaid areas, of applications is achieved by thorough testing of these agents on the basis of standardized test methods, such as the guidelines of the German Association for Hygiene and Microbiology (DGHM) in Germany or the guidelines of the French Association for Standardization (AFNOR) in France. Examples of further standards are listed below:















DIN EN 1040
Chemical disinfectants and antiseptics (basic test)


DIN EN 1276
Chemical disinfectants and antiseptics



Bactericidal action in the fields of foods, industry, home and public



institutions


DIN EN 1499
Disinfecting hand washing


DIN EN 1500
Hygienic hand disinfection


DIN EN 12054
Chemical disinfectants and antiseptics



Products for hygienic and surgical hand disinfection and hand washing -



bactericidal effect


DIN EN 12791
Surgical hand disinfectants


AFNOR T 72 300
Bactericidal effectiveness of antiseptics and disinfectants that are



employed as liquid mixed in water


AFNOR T 72 170
Bactericidal effectiveness in the presence of interfering substances


NF EN 1040
Bactericidal effectiveness of antiseptics and chemical disinfectants


NF EN 1275
Fungicidal effectiveness of antiseptics and chemical disinfectants









In the capacity of pharmaceuticals, antiseptics are further subject to legally governed approval and registration procedures.


For example, as can be seen from German Patent DE 4328828 A, various methods are available for achieving hand disinfection. Explicitly mentioned therein are the alcoholic hand disinfection methods that are standard in Germany as well as the scrub methods of hand disinfection. Products intended for hand disinfection among other purposes must satisfy at least the minimum requirements indicated in the aforesaid standards if they are to be certified as conforming with those standards and included as preparations in the disinfection list of the DGHM.


Commercially available disinfectants, especially skin and hand disinfectants, are usually composed of alcohol or mixtures of alcohols, optionally of active ingredients, which remain on the skin after evaporation of the alcohol components and which can be, for example, nonvolatile antimicrobial substances and/or common skin-care substances, and possibly other auxiliaries. If the alcohol component is used alone as the antimicrobial agent, the alcohol concentration in the product is to be chosen such that a disinfectant effect is assured even after evaporation of part of the alcohol. In this connection, it is known that this is the case for ethanolic compositions having an alcohol concentration of at least 52 wt %.


To address the disadvantages of alcoholic disinfectant solutions applied for skin and hand disinfection, thickeners have been added to such disinfectant solutions in order to increase the viscosity of these agents. Disadvantages include especially the difficulty of dosing due to the fact that the needed quantity of disinfectant often cannot be distributed uniformly over the skin or the hands and that aqueous alcohol solutions drip very easily from the hands. An example for added thickeners is found in European Patent EP 0604848 B, wherein the subject matter is a fast-drying disinfectant composition. As thickener there is described a combination of carboxyvinyl polymers and hydroxypropylmethylcellulose, wherein the total weight of the two components in the disinfectant composition is not greater than 3 wt %.


Also known are antimicrobial alcoholic gel compositions for skin and hand disinfection containing moisturizers and skin-care substances, as described in, for example, U.S. Pat. No. 4,956,170. In these compositions, cross-linked partly neutralized or neutralized acrylic acid polymers are used as thickeners. The antibacterial agent used in these compositions is 60 to 75 wt % of alcohol such as ethanol, isopropyl alcohol or mixtures thereof. Regarding the emollients contained in these gel compositions, especially petrolatum and other mineral-oil products that can be used in cosmetic preparations, as well as further hydrophobic constituents that can be used safely not only in cosmetics but also in disinfectants, it has been found that the use of such constituents in alcoholic gel compositions having high alcohol concentrations is highly detrimental to the stability of such gels, because the gels lose their viscosity and therefore their stability in the course of time during storage, and the compositions deliquesce. In general, it has been found that the gel stability suffers with increasing alcohol concentration, especially at alcohol concentrations higher than 60 wt %.


Such high alcohol concentrations, especially in gel compositions containing alcohol as the sole active component, are unavoidable, however, in order that such agents can also be certified as disinfectants for hand disinfection.


German Patent DE 10132382 discloses a simple, economic production method for the production of stable disinfectant hand-care and skin-care gels having high alcohol concentration, permitting the production of disinfectant hand-care gels that contain care components, that satisfy the standards


















DIN EN 1499
Disinfecting hand washing



DIN EN 1500
Hygienic hand disinfection











among others directly without further additional antimicrobial adjuvants, and that also have a hepatitis B activity. Although it has been shown that the application of a disinfectant agent in gel form is to be preferred to the application of a disinfectant agent in liquid form, especially as regards its drying-out tendency, such disinfectant alcoholic gel compositions nevertheless have the disadvantage that they must lose their gel structure upon being applied on the skin, in order to ensure uniform wetting of the skin areas and thus a safe disinfectant action.


Also known are alcoholic cleaning foam compositions, which are dispensed by commercially available pump-foam systems, which are to be found mainly in sanitary units of hospitals, doctors' and dentists' offices, schools, kindergartens and nursing institutions, such as old-age homes, sanatoriums, etc. The alcohol concentration of such foam compositions is only around 40 wt %, however, because the instability of the foams increases at higher alcohol concentrations. This can also be regarded as the reason why the advantageous form of application by means of foam, which is even more manageable than alcoholic gels, has not yet been considered for disinfectants, especially not for skin and hand disinfection, because of the low alcohol concentration of the products that have been commercially available heretofore.


SUMMARY OF THE INVENTION

It is an object of the present invention to provide an alcoholic foam composition that can be dispensed as pump foam, particularly via standard pump-foam systems, to the consumer for disinfection purposes, preferably for skin and hand disinfection.


It is another object of the present invention to provide an alcoholic foam that is stabilized in such a way that alcoholic foam having an alcohol concentration of at least 52 wt %, especially greater than 60 wt % of alcohol can be dispensed in order to ensure safe disinfection, especially skin and hand disinfection.


This and other objects have been achieved by the present invention the first embodiment of which includes an alcoholic foam composition, comprising:

    • a) at least 52 to ≦99 wt %, relative to the total quantity of the foam composition, of an alcohol or mixture of alcohols,
    • b) a surfactant or a surfactant mixture,
    • c) at least one polyalkylene glycol,
    • d) optionally, at least one foam stabilizer,
    • e) optionally, at least one member selected from the group consisting of cosmetic auxiliaries, adjuvants, active ingredients, and mixtures thereof, and
    • f) optionally water,


wherein the surface tension of component b) lies in the range of ±15 dyn/cm of the surface tension of component a) or corresponds to the surface tension of component a), and


wherein the sum of components a) to f) is 100 wt % relative to the total quantity of the foam composition.







DETAILED DESCRIPTION OF THE INVENTION

The present invention provides an alcoholic foam composition for disinfection, especially a pump-foam formulation, which contains the components

    • a) at least 52 to ≦99 wt %, relative to the total quantity of the foam composition, of an alcohol or mixture of alcohols,
    • b) a surfactant or a surfactant mixture,
    • c) at least one polyalkylene glycol,
    • d) optionally, at least one foam stabilizer,
    • e) optionally, at least one member selected from the group consisting of cosmetic auxiliaries, adjuvants, active ingredients, and mixtures thereof, and
    • f) optionally water,


      wherein the surface tension of component b) is in the range of ±15 dyn/cm of the surface tension of component a) or corresponds to the surface tension of component a), and the sum of components a) to f) is 100 wt % relative to the total quantity of the foam composition. In other words, the surface tension of component b) is in the range of not less than about 15 dyn/cm below the surface tension of component a) and not more than about 15 dyn/cm above the surface tension of component a).


It was completely surprising that such alcoholic foam compositions, which preferably are suitable for skin and hand disinfection and which contain at least 52 wt % relative to the total quantity of the foam composition, can be dispensed as foam via standard pump-foam systems, without suffering spontaneous foam breaking because of the high alcohol concentration in the composition. In particular, it would have been expected of such high alcohol concentrations that the alcohol components of such foam compositions would act merely as a solvent at an alcohol concentration of higher than 50 wt %, whereby the surface-active effects of the surfactants and accordingly their foaming ability also would be lowered. Such effects were not observed, however. To the contrary, it was found that stable voluminous foams for disinfection purposes could be produced with the foam compositions according to the present invention in standard pump-foam systems.


According to the present invention, the surface tension of component b) preferably lies in the range of ≧20 to ≦40 dyn/cm. The surface tension of component b) includes all values and subvalues therebetween, especially including 22, 24, 26, 28, 30, 32, 34, 36 and 38 dyn/cm.


Preferably, the alcoholic foam composition contains, as component a), alcohols of the general formula

R—OH

in which R denotes an aliphatic straight-chain or branched hydrocarbon group that has 1 to 8 carbon atoms and that can be contained alone or in mixtures in the foam according to the present invention.


Examples of such alcohols are methanol, ethanol, 1-propanol, 2-propanol, 1-butanol, isobutyl alcohol, tert-butyl alcohol, the amyl alcohols, 1-, 2-, 3-pentanol or neopentyl alcohol as well as 1-hexanol, ethanol being particularly preferred as component a).


Preferably, the foam composition contains at least 52 to 99 wt %, preferably 55 to 96 wt % and especially more than 65 wt % of ethanol. The amount of ethanol includes all values and subvalues therebetween, especially including 55, 60, 65, 70, 75, 80, 85, 90 and 95 wt %. As regards the disinfectant action, it is particularly advantageous for the alcoholic foams according to the present invention to contain more than 80 wt % of alcohol.


As component b), the foam compositions according to the present invention can contain respectively a surfactant or surfactant mixture, with the proviso that the surface tension of the surfactant or of the surfactant mixture contained in the foam composition lies within the range of ±15 dyn/cm of the surface tension of component a), meaning the alcohol component, or corresponds to the surface tension of component a).


Every surfactant or surfactant mixture that satisfies the foregoing proviso is suitable as component b) of the foam compositions. The total quantity of the surfactant or surfactant mixture is 0.5 to 20, preferably 1 to 10 and particularly preferably 2 to 5 wt % relative to the total quantity of the foam composition. The amount of surfactant or surfactant mixture includes all values and subvalues therebetween, especially including 1, 2, 4, 6, 8, 10, 12, 14, 16, and 18 wt %


Such surfactants are, among other substances, silicone compounds, such as dimethylpolysiloxanes, methylphenylpolysiloxanes, cyclic silicones as well as silicone compounds modified by amino, fatty acid, alcohol, polyether, epoxy, fluoro, glycoside and or alkyl groups. Preferred as silicone compounds according to the present invention are polysiloxane-polyether copolymers [INCI(CFTA): dimethicone copolyol], which are available from the company named Goldschmidt AG of Essen under the trade name ABIL®, especially polysiloxane-polyether copolymers of the B 88 product family, such as ABIL® B 8843, ABIL® B 8851, ABIL® B 8852, ABIL® B 8863, ABIL® B 88183 and ABIL® B 88184. Particularly preferably, the foam compositions according to the present invention contain, as component b), polysiloxane-polyether copolymers available under the trade name ABIL® B 8832 (bis-PEG/PPG-20/20 dimethicone).


As further suitable surfactants or surfactant mixtures there can be mentioned the group of fluoro surfactants, which can be present as component b) in the foams, either alone or as mixture of various fluoro surfactants, especially also as mixtures with polysiloxane-polyether copolymers. Such suitable surfactants are, for example, tetraalkylammonium perfluoroalkylsulfonates, preferably the tetraethylammonium perfluorooctanesulfonate that is commercially available under the trade name FLUORTENSIDE FT-248.


Furthermore, the foam compositions contain, as component c), at least one polyalkylene glycol, which can be present preferably in proportions of 0.01 to 3, especially 0.01 to 0.2 and particularly preferably 0.05 to 0.2 wt % relative to the total quantity of the foam composition. The amount of polyalkylene glycol includes all values and subvalues therebetween, specially including 0.05, 0.1, 0.5, 1, 1.5, 2, and 2.5 wt %. Preferred polyalkylene glycols according to the present invention are in particular polyethylene oxide homopolymers with a molecular weight of 100,000 to 8,000,000, which are available as commercial products on the market under the trademark Polyox®, such as Polyox® WSR N-10, Polyox® WSR N-80 (PEG-5M), Polyox® WSR N-750 (PEG-7M), Polyox® WSR N-3000 (PEG-14M), Polyox® WSR N-3333, Polyox® WSR-205 (PEG-14M), Polyox® WSR-1105, Polyox®) WSR N-12K, Polyox® WSR N-60K (PEG-45M) and Polyox® WSR-301.


The foam compositions contain optionally at least one foam stabilizer, which is present as component d) in the foam in a proportion of 0.01 to 20 wt %, preferably 0.5 to 3 wt % relative to the total quantity of the foam composition. The amount of foam stabilizer includes all values and subvalues therebetween, especially including 0.05, 0.1, 0.5, 1, 2, 4, 6, 8, 10, 12, 14, 16 and 18 wt %. Examples of suitable foam stabilizers are polysaccharides, especially xanthan gum, guar-guar, agar-agar, alginates and tyloses, cellulose ethers, such as carboxymethylcellulose, ethylcellulose, hydroxypropylcellulose, methylcellulose, cellulose mixed ethers, such as carboxymethylhydroxyethylcellulose, ethylhydroxyethylcellulose, methoxyhydroxyalkylcelluloses, methylhydroxyalkylcelluloses, such as methylhydroxyethylcellulose, methylhydroxypropylcellulose, methylhydroxybutylcellulose. Preferred according to the present invention are alkylcelluloses, especially methylcellulose and ethylcellulose that are commercially available under the trade names METHOCEL® and ETHOCEL®,


Besides water, the alcoholic foams according to the present invention can, if necessary, contain auxiliaries, adjuvants and/or active ingredients, such as dyes, solubilizers, complexing agents, sequestering agents, light-protecting filters or perfumes and scents, pH regulators, stabilizers, preferably cetearyl alcohol and/or hydrogenated castor oils, such as trihydroxystearin, preservatives, antioxidants and/or oil-based or water-based care components as component e), especially in standard proportions of preferably 0.05 to 5 wt % relative to the total weight of the foams. The amount of additional components includes all values and subvalues therebetween, especially including 0.05, 0.1, 0.5, 1, 1.5, 2, 2.5, 3, 3.5, 4 and 4.5 wt %. These optional constituents of component e) can normally be present in proportions of 0 to 5 wt % relative to the total weight of the foam, but the person skilled in the art will choose the weight proportion of component e) such that no impairment of foam formation occurs.


In a preferred embodiment of the present invention, the foams contain 55 to 96 wt % of ethanol, 1 to 10 wt % of bis-PEG/PPG-20/20 dimethicone as silicone surfactant, 0.0 to 3 wt % of ethylcellulose polymer as stabilizer in combination with a PEG polymer, selected from PEG 7M to PEG 45M, preferably 0.05 to 2 wt %, whereby very effectively disinfecting foams with excellent stability are obtained in standard pump-foam systems. These amounts are given based on the total weight of the foam composition. The amount of ethanol includes all values and subvalues therebetween, especially including 60, 65, 70, 75, 80, 85 and 90 wt %. The amount of bis-PEG/PPG-20/20 dimethicone includes all values and subvalues therebetween, especially including 0.1, 0.5, 1, 2, 3, 4, 5, 6, 7, 8 and 9 wt %. The amount of ethylcellulose polymer includes all values and subvalues therebetween, especially including 0.1, 0.5, 1, 1.5, 2 and 2.5 wt %. The amount of PEG polymer includes all values and subvalues therebetween, especially including 0.1, 0.5, 1, and 1.5 wt %.


The alcoholic foams according to the present invention can be used particularly advantageously as disinfectants, for example as antiseptics for wound, skin, stools and sputum disinfection as well as instrument disinfection, as laundry and surface disinfectants and, particularly preferably according to the present invention, as skin and hand disinfectants.


The possible optional addition of nonvolatile antimicrobial substances in the foams is used in particular to intensify the disinfectant properties of the alcohol component. Of course, this depends on the area of application for which the foams are intended.


Antimicrobial substances can be present if necessary and can be used in the foams preferably alone or as combinations of a plurality of disinfectant active ingredients. Preferred are invert soaps, such as cationic surfactants, quaternary ammonium compounds, including benzalkonium chlorides or benzethonium chloride, biguanide compounds, such as chlorhexidine salts, phenol compounds, cresols, per compounds, iodine compounds, such as polyvidone iodine, organic acids, etc.


Nevertheless, the addition of such antimicrobial active ingredients may not be not necessary, since the foams have such a high alcohol concentration that the alcohol component functions as the disinfectant active ingredient on its own.


According to the present invention, care and/or moisturizing active ingredients, which can be contained optionally in the foams, especially for use of the foams as skin and hand disinfectants, are active ingredients that remain on the skin after evaporation of the alcohol component of the foam, for example standard skin-care substances such as dexpanthenol, glycerin, 1,2-propanediol, sorbitol, 1,3-butylene glycol, polyethylene glycol and other polyalcohols, hyaluronic acids, urea, chamomile extracts, alkoxylated cetyl alcohols and/or nonvolatile antimicrobial substances.


Since, (luring use as skin and hand disinfectants, the high alcohol proportion in the foams causes drying out of the treated skin areas during application, the use of at least one skin-care substance and/or one moisturizer is actually indispensable in daily practice with regard to frequent application of such disinfectants.


Also advantageous for the use of the foams for skin and hand disinfection is a constituent of natural plant tannins, such as ladies' mantle (Alchemilla xanthochlora, Rosaceae), tormentil rootstock (Potentilla erecta, Rosaceae), oak bark (Quercus petraea and Quercus robur, Fagaceae), ratanhia root (Krameria lappacea syn. K. triandra, Krameriaceae), witch hazel leaves (Hamamelis virginiana, Hamamelidaceae) and bilberries (Vaccinium myrtillus, Ericaceae) and natural synthetic tannins, such as Na bichlorophenylsulfamine, preferably in a proportion of 0.01 to 5 wt % of active substance relative to the total quantity of the foams. Of those, Hamamelis virginiana is particularly preferred as tannin. The amount of tannin includes all values and subvalues therebetween, especially including 0.05, 0.1, 0.5, 1, 1.5, 2, 2.5, 3, 3.5, 4 and 4.5 wt %.


Despite their high alcohol concentration, the foams are characterized by very good stability, and so stable disinfectant foams, especially for skin and hand disinfection, are made available by the present invention. Even without further additional antimicrobial adjuvants, these foams satisfy the standards


















DIN EN 1499
Disinfecting hand washing



DIN EN 1500
Hygienic hand disinfection











among others, and in addition have hepatitis B activity. The latter effect especially is particularly advantageous, since the hepatitis B virus, just as the HIV virus that is responsible for the spread of AIDS (acquired immune deficiency syndrome), is communicable but is more stable and more infectious than the HIV virus. Thus, all precautions against transmission of hepatitis B are also preventive against the HIV virus (see Deutsches Ärzteblatt 84, No. 18, p. B 874 of 30 Apr. 1987).


Since the foams according to the present invention can have alcohol concentrations of >70 vol % or 60 wt % relative to the total quantity of the foam, they also have virus activity against “naked” or nonenveloped viruses, such as polioviruses and adenoviruses, and so such alcoholic foams are of particular interest as a form of application, especially for skin disinfection.


It is also advantageous that the foams according to the present invention can be dispensed in particular as pump foams via standard pump-foam systems to the consumers for disinfection purposes, preferably for skin and hand disinfection, especially because such pump foams can usually be manufactured inexpensively and simply as aerosol-base foams. Examples include the commercially available pump-foam systems of companies such as Airspray (Netherlands), Keltec (Netherlands), Ophardt (Germany), Brightwell (United Kingdom) and Supermatic (Switzerland).


The foam compositions of the present invention can be obtained by mixing components a) to c) and optionally d), e) and/or f).


Foam compositions preferred according to the present invention (all data in wt % relative to the total quantity of the foam composition):















Example













A
B
C
D
E


















Alcohol or
55.0
60.0
70.0
80.0
90.0



alcohol



mixture



Polyethylene
0.1
0.1
0.1
0.1
0.05



glycol



homopolymer



Stabilizer
0.2
0.2
0.2
0.2
0.1



Surfactant or
3.0
3.0
4.0
4.0
3.0



surfactant



mixture



Water
41.7
36.7
25.7
15.7
6.85











Foam compositions preferred according to the present invention for skin and hand disinfection (all data in wt % relative to the total quantity of the foam composition):















Example











1
2
3
















Ethanol
55.0
80.0
90.0



PEG-14M
0.1
0.1
0.05



Ethylcellulose
0.2
0.2
0.1



Bis-PEG/PPG-
3.0
4.0
3.0



20/20



dimethicone



Demineralized
41.7
15.7
6.85



water










German patent application 10 2004 062 775.4 filed, Dec. 21, 2004, is incorporated herein by reference.


Numerous modifications and variations on the present invention are possible in light of the above teachings. It is therefore to be understood that within the scope of the appended claims, the invention may be practiced otherwise than as specifically described herein.

Claims
  • 1. An alcoholic foamable composition comprising: a) 52 to 99 wt. %, relative to the total quantity of the foamable composition, of an alcohol or mixture of alcohols of formula R—OH wherein R denotes an aliphatic straight-chain or branched hydrocarbon group having 1 to 8 carbon atoms;b) 0.5 to 20 wt. %, relative to the total quantity of the foamable composition, of at least one silicone surfactant selected from the group consisting of methylphenylpolysiloxanes, cyclic silicones, bis-PEG/PPG-20/20 dimethicone, PEG/PPG-14/4 dimethicone, PEG/PPG-4/12 dimethicone, PEG/PPG-20/20 dimethicone, and PEG/PPG-20/6 dimethicone, wherein said at least one silicone surfactant is not fluorinated and the surface tension of said at least one silicone surfactant lies within the range of ±15 dyn/cm of the surface tension of component (a);c) 0.01 to 3 wt. %, relative to the total quantity of the foamable composition, of at least one polyalkylene glycol;d) optionally, 0.01 to 20 wt. %, relative to the total quantity of the foamable composition, of at least one foam stabilizer;e) optionally, at least one member selected from the group consisting of cosmetic auxiliaries, adjuvants, active ingredients, and mixtures thereof; andf) optionally, water;wherein said alcoholic foamable composition is in the form of a pump-foam formulation before it is foamed, said pump-foam formulation being capable of forming a stabilized pump-foam.
  • 2. The alcoholic foamable composition according to claim 1, wherein the surface tension of component b) is ≧20 to ≦40 dyn/cm.
  • 3. The alcoholic foamable composition according to claim 1, wherein component a) comprises at least one member selected from the group consisting of methanol, ethanol, 1-propanol, 2-propanol, and mixtures thereof.
  • 4. The alcoholic foamable composition according to claim 1, wherein component a) is ethanol.
  • 5. The alcoholic foamable composition according to claim 1, wherein at least 52 to ≦99 wt %, relative to the total quantity of the foam composition, of ethanol is contained in the foamable composition alone or as part of component a).
  • 6. The alcoholic foamable composition according to claim 1, wherein greater than 60 wt %, relative to the total quantity of the foamable composition, of ethanol is contained in the foamable composition as component a).
  • 7. The alcoholic foamable composition according to claim 1, wherein the at least one polyalkylene glycol is selected from polyethylene oxide homopolymers.
  • 8. The alcoholic foamable composition according to claim 7, wherein one or more of the polyethylene oxide homopolymers are selected from the group consisting of PEG-5M, PEG-7M, PEG-14M, PEG-23M, PEG-45M, and PEG-90M.
  • 9. The alcoholic foamable composition according to claim 1, wherein the at least one polyalkylene glycol is selected from polyethylene oxide homopolymers having a molecular weight of from 100,000 to 8,000,000.
  • 10. The alcoholic foamable composition according to claim 1, wherein 0.01 to 10 wt %, relative to the total quantity of the foamable composition, of at least one foam stabilizer is contained in the foam as component d).
  • 11. The alcoholic foamable composition according to claim 1, wherein component d) comprises an alkylcellulose.
  • 12. The alcoholic foamable composition according to claim 1, comprising: 55 to 96 wt % of ethanol, 1 to 10 wt % of at least one of said silicone surfactants, 0.0 to 3 wt % of ethylcellulose polymer, and 0.05 to 2 wt % PEG polymer selected from the group consisting of PEG 7M to PEG 45M and mixtures thereof.
  • 13. A disinfectant, comprising: the alcoholic foamable composition according to claim 1.
  • 14. An antiseptic for wound, skin, stools and sputum disinfection or instrument disinfection, comprising: the alcoholic foamable composition according to claim 1.
  • 15. A laundry and surface disinfectant, comprising: the alcoholic foamable composition according to claim 1.
  • 16. A skin and hand disinfectant, comprising: the alcoholic foamable composition according to claim 1.
  • 17. A method of disinfecting skin with a stabilized pump foam said method comprising: applying a stabilized pump foam to the skin of a consumer, wherein stabilized pump foam is formed from the alcoholic foamable composition according to claim 1.
  • 18. The method of claim 17, wherein the stabilized pump foam is applied to a hand of the consumer.
  • 19. The method of claim 17, wherein component a) of the foamable composition is ethanol at a concentration of greater than 60 wt %, relative to the total quantity of the foam composition.
  • 20. A method of dispensing a stabilized pump foam, said method comprising: dispensing a stabilized pump foam from a pump-foam system, wherein the stabilized pump foam is formed from the alcoholic foamable composition according to claim 1.
  • 21. A pump-foam system for dispensing a stabilized pump foam, said pump-foam system comprising: the alcoholic foamable composition according to claim 1 to be dispensed via the pump-foam system.
Priority Claims (1)
Number Date Country Kind
10 2004 062 775 Dec 2004 DE national
US Referenced Citations (311)
Number Name Date Kind
2054989 Moore Sep 1936 A
2559749 Benning Jul 1951 A
2597702 Benning May 1952 A
2599140 Taub Jun 1952 A
2855367 Buck Oct 1958 A
3131153 Klausner Apr 1964 A
3395214 Mummert Jul 1968 A
3708435 Starkman Jan 1973 A
3709437 Wright Jan 1973 A
3770648 Mackles Nov 1973 A
3787566 Gauvreau et al. Jan 1974 A
3824303 Lanzet Jul 1974 A
3928558 Cheesman et al. Dec 1975 A
3962150 Viola Jun 1976 A
3963507 Kuramoto et al. Jun 1976 A
4018364 Wright Apr 1977 A
4086178 Walker Apr 1978 A
4220665 Klein Sep 1980 A
4311695 Starch Jan 1982 A
4313978 Stevens Feb 1982 A
4336151 Like et al. Jun 1982 A
4440652 Hunter Apr 1984 A
4440653 Briscoe Apr 1984 A
4454060 Lai et al. Jun 1984 A
4478853 Chaussee Oct 1984 A
4511486 Shah Apr 1985 A
4559226 Fogel et al. Dec 1985 A
4567038 Ciaudelli et al. Jan 1986 A
4584189 Leipold Apr 1986 A
4613592 Benzoni Sep 1986 A
4714568 Hurnik et al. Dec 1987 A
4772592 Benzoni Sep 1988 A
4826828 Wilmott et al. May 1989 A
4839166 Grollier et al. Jun 1989 A
4839167 Yamamoto et al. Jun 1989 A
4857302 Decker et al. Aug 1989 A
4897262 Nandagiri et al. Jan 1990 A
4906459 Cobb et al. Mar 1990 A
4915934 Tomlinson Apr 1990 A
4919837 Glack Apr 1990 A
4956170 Lee Sep 1990 A
4956173 Le Fur et al. Sep 1990 A
4981678 Tomlinson Jan 1991 A
4983377 Murphy et al. Jan 1991 A
4986922 Snow et al. Jan 1991 A
4988453 Chambers Jan 1991 A
5015228 Columbus et al. May 1991 A
5043088 Falla Aug 1991 A
5047249 Rothman et al. Sep 1991 A
5073371 Turner et al. Dec 1991 A
5100658 Bolich, Jr. et al. Mar 1992 A
5104646 Bolich, Jr. et al. Apr 1992 A
5122541 Eggensperger et al. Jun 1992 A
5128123 Brewster et al. Jul 1992 A
5167950 Lins Dec 1992 A
5180584 Sebag et al. Jan 1993 A
5204099 Barbier et al. Apr 1993 A
D338585 Bell Aug 1993 S
5232691 Lemole Aug 1993 A
5256401 Duckenfield Oct 1993 A
5265772 Bartasevich Nov 1993 A
5266598 Ninomiya et al. Nov 1993 A
D343751 Bell Feb 1994 S
5288486 White Feb 1994 A
5290555 Guthauser et al. Mar 1994 A
D346332 Kanfer Apr 1994 S
5300284 Wiechers et al. Apr 1994 A
5314684 Horoschak et al. May 1994 A
5336497 Guerrero et al. Aug 1994 A
5352437 Nakagawa et al. Oct 1994 A
5362484 Wood et al. Nov 1994 A
5370267 Schroeder Dec 1994 A
5415811 Wile May 1995 A
5441178 Wysocki Aug 1995 A
5443236 Bell Aug 1995 A
5445288 Banks Aug 1995 A
5449137 Bell Sep 1995 A
5462688 Lippman Oct 1995 A
D365509 Bell Dec 1995 S
D365518 Wysocki Dec 1995 S
D365755 Kanfer Jan 1996 S
5484597 Slavtcheff et al. Jan 1996 A
5494533 Woodin, Jr. et al. Feb 1996 A
5523014 Dolan Jun 1996 A
5547662 Khan et al. Aug 1996 A
5549888 Venkateswaran Aug 1996 A
5558453 Bell Sep 1996 A
5567428 Hughes Oct 1996 A
5587358 Sukigara Dec 1996 A
5607980 McAfee et al. Mar 1997 A
5612324 Guang Lin et al. Mar 1997 A
5625659 Sears Apr 1997 A
5626853 Bara et al. May 1997 A
5629006 Hoang May 1997 A
5635462 Fendler Jun 1997 A
5635469 Fowler et al. Jun 1997 A
D383001 Bell Sep 1997 S
5662893 George et al. Sep 1997 A
5665332 Mundschenk et al. Sep 1997 A
D385795 Wysocki Nov 1997 S
5690921 Lang et al. Nov 1997 A
5693255 Okamoto et al. Dec 1997 A
5718353 Kanfer Feb 1998 A
5719113 Fendler Feb 1998 A
D392136 Ross Mar 1998 S
5725131 Bell et al. Mar 1998 A
5733535 Hollingshead et al. Mar 1998 A
5756077 Syed et al. May 1998 A
5767161 Stroppolo et al. Jun 1998 A
5776430 Osborne et al. Jul 1998 A
5789371 Tracy et al. Aug 1998 A
5824320 Rouillard et al. Oct 1998 A
D400799 Bell Nov 1998 S
5834516 O'Lenick, Jr. Nov 1998 A
5856347 Hashiguchi et al. Jan 1999 A
5863884 Lafreniere Jan 1999 A
5902778 Hartmann et al. May 1999 A
5906808 Osborne May 1999 A
D411456 Mast Jun 1999 S
5908619 Scholz Jun 1999 A
5919439 Torgerson et al. Jul 1999 A
5922663 Gabriel et al. Jul 1999 A
5928993 Johansson Jul 1999 A
5935587 Cauwet et al. Aug 1999 A
5944227 Schroeder Aug 1999 A
5951993 Scholz Sep 1999 A
5952290 Li et al. Sep 1999 A
5955408 Kaiser Sep 1999 A
5955416 Baillely et al. Sep 1999 A
D415343 Maddox Oct 1999 S
5972356 Peffly et al. Oct 1999 A
D416417 Ross Nov 1999 S
5980876 Peffy Nov 1999 A
5996851 Dolan Dec 1999 A
D418708 Kanfer Jan 2000 S
6019997 Scholz et al. Feb 2000 A
6022551 Jampani et al. Feb 2000 A
6039965 Donian et al. Mar 2000 A
D422828 Kanfer Apr 2000 S
6065639 Maddox May 2000 A
6086856 Saferstein et al. Jul 2000 A
6090395 Asmus Jul 2000 A
6117440 Suh Sep 2000 A
6130253 Franklin et al. Oct 2000 A
6183766 Sine et al. Feb 2001 B1
6217885 Roder et al. Apr 2001 B1
6255265 Van Gunst Jul 2001 B1
6262128 Stern et al. Jul 2001 B1
6265363 Viscovitz Jul 2001 B1
6267946 Barnhart Jul 2001 B1
6274124 Vollhardt Aug 2001 B1
6277359 Raths et al. Aug 2001 B1
6319958 Johnson et al. Nov 2001 B1
6333039 Fendler et al. Dec 2001 B1
6339165 Endo et al. Jan 2002 B1
6342470 Aronson Jan 2002 B1
6352701 Scholz et al. Mar 2002 B1
6358914 Gabriel et al. Mar 2002 B1
6376438 Rosenberger et al. Apr 2002 B1
6383505 Kaiser May 2002 B1
6383997 McManus May 2002 B1
6410005 Galleguillos et al. Jun 2002 B1
6423329 Sine et al. Jul 2002 B1
6462002 Saxena Oct 2002 B2
6471983 Veeger et al. Oct 2002 B1
6472356 Narula et al. Oct 2002 B2
6479442 Berube Nov 2002 B1
6489275 Veeger et al. Dec 2002 B1
6491840 Frankenbach et al. Dec 2002 B1
6497864 Samain et al. Dec 2002 B1
6518228 Jorgensen Feb 2003 B1
6524494 Hart et al. Feb 2003 B2
6524594 Santora Feb 2003 B1
6528544 Stern et al. Mar 2003 B2
6534069 Asmus et al. Mar 2003 B1
6537952 Hayward Mar 2003 B2
6551605 Bondo Apr 2003 B2
6555508 Paul et al. Apr 2003 B1
6562360 Scholz May 2003 B2
6585711 Asmus et al. Jul 2003 B1
6592880 Jager Jul 2003 B1
6610315 Scholz Aug 2003 B2
6617294 Narula et al. Sep 2003 B2
6623744 Asmus Sep 2003 B2
6638527 Gott Oct 2003 B2
6641825 Scholz Nov 2003 B2
6664256 Oohkuchietal Dec 2003 B1
6664356 Shih Dec 2003 B1
6666217 Elsner Dec 2003 B2
6685952 Ma et al. Feb 2004 B1
6689593 Millis Feb 2004 B2
6696397 Staats Feb 2004 B2
6703007 Glenn, Jr. Mar 2004 B2
6706675 Demson Mar 2004 B1
6709647 Bhakoo Mar 2004 B2
6710022 Kwetkat et al. Mar 2004 B1
6723689 Hoang Apr 2004 B1
6730621 Gott May 2004 B2
6759376 Zhang Jul 2004 B2
6762158 Lukenbach Jul 2004 B2
6777384 Raths et al. Aug 2004 B2
6780826 Zhang Aug 2004 B2
6794345 Elsner et al. Sep 2004 B2
6797687 Kischket et al. Sep 2004 B2
6805141 Elsner et al. Oct 2004 B2
6815410 Boutique Nov 2004 B2
6818603 Aleles Nov 2004 B2
6846846 Modak et al. Jan 2005 B2
6875539 Ophardt Apr 2005 B2
6884763 Willard Apr 2005 B2
6946120 Wai-Chiu et al. Sep 2005 B2
6977082 Seitz, Jr. et al. Dec 2005 B2
7081246 Asmus et al. Jul 2006 B2
7141237 Abram et al. Nov 2006 B2
7163916 Allef et al. Jan 2007 B2
7164041 Moore et al. Jan 2007 B1
7166435 Rosenbloom Jan 2007 B2
7199090 Koivisto Apr 2007 B2
7241452 Veeger et al. Jul 2007 B2
7297675 Allef et al. Nov 2007 B2
7393817 Kwetkat et al. Jul 2008 B2
7530477 Ophardt May 2009 B2
7547732 Moore et al. Jun 2009 B2
7566460 Asmus Jul 2009 B2
7651990 Asmus Jan 2010 B2
7670615 Veeger et al. Mar 2010 B2
7683018 Koivisto et al. Mar 2010 B2
7723279 Lestage et al. May 2010 B2
7790663 Lestage et al. Sep 2010 B2
7803390 Asmus et al. Sep 2010 B2
7842725 Wegner et al. Nov 2010 B2
8058315 Wegner et al. Nov 2011 B2
20020022660 Jampani Feb 2002 A1
20020028187 Nekludoff et al. Mar 2002 A1
20020039562 Kobayashi et al. Apr 2002 A1
20020098159 Wei et al. Jul 2002 A1
20020108640 Barger et al. Aug 2002 A1
20020127253 Scholz et al. Sep 2002 A1
20020142018 Scholz et al. Oct 2002 A1
20020151446 Piterski et al. Oct 2002 A1
20020160029 Asmus et al. Oct 2002 A1
20020160924 Bertrem et al. Oct 2002 A1
20020177535 Piterski et al. Nov 2002 A1
20020187908 Gagilardi et al. Dec 2002 A1
20030134761 Sebillotte-Arnaud et al. Jul 2003 A1
20030203824 Staats Oct 2003 A1
20030211066 Scholz et al. Nov 2003 A1
20030213542 Kobayashi et al. Nov 2003 A1
20030215418 Asmus et al. Nov 2003 A1
20030235550 Pan et al. Dec 2003 A1
20040001797 Saud et al. Jan 2004 A1
20040071748 Asmus et al. Apr 2004 A1
20040072700 Gupta Apr 2004 A1
20040102429 Modak May 2004 A1
20040170592 Veeger et al. Sep 2004 A1
20040191195 Collins et al. Sep 2004 A1
20040191274 Grayson et al. Sep 2004 A1
20040219227 Modak et al. Nov 2004 A1
20040241099 Popp et al. Dec 2004 A1
20040247685 Modak et al. Dec 2004 A1
20040265240 Tamarkin et al. Dec 2004 A1
20050003990 Smith et al. Jan 2005 A1
20050031580 Allef et al. Feb 2005 A1
20050031653 Kwetkat et al. Feb 2005 A1
20050063925 Candau et al. Mar 2005 A1
20050109981 Tucker et al. May 2005 A1
20050129626 Koivisto et al. Jun 2005 A1
20050152931 SaNogueira et al. Jul 2005 A1
20050222001 Baumeister et al. Oct 2005 A1
20050226838 Krause et al. Oct 2005 A1
20050277574 Niedbala et al. Dec 2005 A1
20060018847 Kroepke et al. Jan 2006 A1
20060104911 Novak May 2006 A1
20060104919 Novak May 2006 A1
20060110416 Ryles et al. May 2006 A1
20060121071 Asmus Jun 2006 A1
20060165627 Allef et al. Jul 2006 A1
20060182690 Veeger Aug 2006 A1
20060198859 Allef et al. Sep 2006 A1
20060204468 Allef et al. Sep 2006 A1
20060257334 Dahms et al. Nov 2006 A1
20060263396 Asmus Nov 2006 A1
20060275226 Dahms et al. Dec 2006 A1
20060281663 Asmus Dec 2006 A1
20070027055 Koivisto et al. Feb 2007 A1
20070041927 Blaeser et al. Feb 2007 A1
20070065383 Fernandez de Castro et al. Mar 2007 A1
20070092470 Allef et al. Apr 2007 A1
20070141007 Glynn et al. Jun 2007 A1
20070148101 Snyder et al. Jun 2007 A1
20070179207 Fernandez de Castro et al. Aug 2007 A1
20070258911 Fernandez de Castro et al. Nov 2007 A1
20080051312 Lestage et al. Feb 2008 A1
20080108704 Asmus et al. May 2008 A1
20080145320 Wenk et al. Jun 2008 A1
20080207767 Dobos Aug 2008 A1
20080293825 Littau et al. Nov 2008 A1
20080305056 Jenni et al. Dec 2008 A1
20090054521 Herrwerth et al. Feb 2009 A1
20090098067 Seidling et al. Apr 2009 A1
20090318570 Veeger et al. Dec 2009 A1
20090326076 Asmus Dec 2009 A1
20100022660 Wegner et al. Jan 2010 A1
20100160415 Koivisto et al. Jun 2010 A1
20100187263 Lestage et al. Jul 2010 A1
20100210499 Allef et al. Aug 2010 A1
20100234475 Wegner et al. Sep 2010 A1
20100327013 Asmus Dec 2010 A1
20100331411 Asmus Dec 2010 A1
20110104079 Snyder et al. May 2011 A1
20110110869 Scholz et al. May 2011 A1
Foreign Referenced Citations (65)
Number Date Country
2003203452 Oct 2004 AU
2 323 780 Apr 2001 CA
2534692 Feb 2005 CA
2587086 Aug 2005 CA
2 587 086 Apr 2006 CA
28 52 593 Jun 1979 DE
3306593 Feb 1983 DE
33 06 593 Sep 1983 DE
19523320 Jan 1997 DE
695 12 841 May 2000 DE
696 30 221 Jul 2004 DE
69512841 May 2005 DE
10 2004 050 211 Apr 2006 DE
0160051 Oct 1984 EP
0 160 051 Nov 1985 EP
0213527 Mar 1987 EP
0117889 Nov 1987 EP
0 260 641 Mar 1988 EP
0384126 Jan 1990 EP
0 384 126 Aug 1990 EP
0 689-767 Jan 1996 EP
0689767 Jan 1996 EP
0882446 Dec 1998 EP
0990412 Apr 2000 EP
1118655 Jul 2001 EP
1 584 323 Oct 2005 EP
1584323 Oct 2005 EP
1 893 197 Mar 2008 EP
1967576 Sep 2008 EP
1811013 Aug 2009 EP
1 010 874 Jul 1979 GB
2010874 Jul 1979 GB
11349418 Dec 1999 JP
07285808 Nov 2007 JP
9307250 Oct 1991 WO
9300089 Jan 1993 WO
WO 9307250 Apr 1993 WO
9501384 Jan 1995 WO
9503772 Feb 1995 WO
9700667 Jan 1997 WO
9700667 Jan 1997 WO
9700668 Jan 1997 WO
WO 9700668 Jan 1997 WO
9920250 Apr 1999 WO
0006107 Feb 2000 WO
0047183 Aug 2000 WO
02062936 Aug 2002 WO
03028671 Sep 2002 WO
WO 03028671 Apr 2003 WO
03034994 May 2003 WO
03053388 Jul 2003 WO
2004000016 Dec 2003 WO
2005030917 Sep 2004 WO
05030917 Apr 2005 WO
2005051341 Jun 2005 WO
2005123012 Jun 2005 WO
2005123012 Dec 2005 WO
2006042588 Apr 2006 WO
2006042588 Apr 2006 WO
2006066888 Jun 2006 WO
2006094387 Sep 2006 WO
2006138111 Dec 2006 WO
2007095008 Aug 2007 WO
2008132621 Nov 2008 WO
2010010475 Jan 2010 WO
Related Publications (1)
Number Date Country
20100069505 A1 Mar 2010 US
Continuations (1)
Number Date Country
Parent 11312559 Dec 2005 US
Child 12624073 US